They will always be cautiously optimistic - especially in biotech. Why? Because no one likes to be sued. If results are good, they will speak for themselves. At this point management has absolutely no interest in pumping up their own stock for a short period of time.
Ann: Oral nadolol data presented to American Thoracic Society, page-3
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IVX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $19.81M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $29.55K | 9.851M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 4451823 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 4794077 | 9 |
View Market Depth
| Last trade - 16.10pm 05/08/2024 (20 minute delay) ? |
| IVX (ASX) Chart |